据中国援圣普疟疾防治顾问组组长郭文峰介绍，2025年以来，顾问组在圣普近200个疟疾流行村开展筛 查和疫点处置，共筛查超过4万人次，发现疟疾病例1000余例。（记者刘杰） 圣普卫生部长塞尔索·马托斯说，疟疾在圣普长期存在，持续威胁人民健康与生命安全。室外喷洒是阻 断疟疾传播链条、加速圣普迈向"零疟疾"目标的有效措施。 中国驻圣普大使馆临时代办郑希表示，中方高度重视两国在疟疾防治领域的合作成果，尤其是中国抗疟 团队提出并实施的"以清除传染源为优先"的防控策略，以及中圣普双方共同构建的"三级防治体系"。她 说，尽管圣普疟疾形势依然严峻，但今年已出现一定好转，室外喷洒将成为推动圣普加快实现消除疟疾 的重要举措。 新华社马普托9月24日电 圣多美消息：室外喷洒灭蚊行动启动仪式23日在非洲岛国圣多美和普林西比 （圣普）考埃区首府圣若昂-多斯安戈拉雷斯的市政广场举行。中国援圣普疟疾防治顾问组、圣普国家 疾控中心和社会各界代表等60余人参加仪式。 圣普国家疾控中心主任博尼法西奥·索萨表示，疟疾是圣普最严重的公共卫生问题之一，去年全国报告 了约7000例疟疾病例。近年来，各方在蚊媒防治方面做出了巨大努力，他对中国援圣普疟疾防 ...

新华社日内瓦9月10日电（记者王露）总部位于日内瓦的全球防治艾滋病、结核病和疟疾基金会（下称 全球基金会）10日发布年度成果报告说，该基金会自2002年成立以来，与合作伙伴共同努力，在艾滋 病、结核病和疟疾防治方面取得重要进展，已成功挽救7000万人的生命。 报告显示，在艾滋病防治方面，2024年，在全球基金会资助的国家和地区，艾滋病病毒感染者中有88% 知晓自身感染状况，79%在接受抗逆转录病毒治疗，74%病毒载量得到抑制，相关指标均创下历史新 高。自2002年以来，在全球基金会资助的国家和地区，与艾滋病相关死亡率已下降82%，艾滋病发病率 下降73%。 全球基金会执行主任彼得·桑兹在一份新闻公报中说，这证明凭借正确的工具、坚实的伙伴关系和持续 投入，我们能够改善全球卫生的发展进程。他呼吁全球卫生界加快行动，减少碎片化和重复性工作，为 各方合作提供便利。 全球基金会是在全球范围内为抗击艾滋病、结核病和疟疾提供资助的非营利性机构，于2002年在联合国 倡议下成立。据介绍，2024年全球基金会向100多个国家和地区投入27亿美元用于加强疾病监测和防 控。 报告同时警告，资金压力、地区冲突等使疾病防控面临新挑战。 ...

哪种动物杀死的人类最多？答案不是犀牛、老虎，甚至也不是鲨鱼，而是帮助疟原虫（Plasmodium）传 播的微小的蚊子。为了应对这种疾病，人们发现了奎宁和青蒿素，学会了使用疫苗、杀虫剂喷雾，以及 疫苗，然而，时至今日，尽管人类进行了诸多干预，每年仍有2.63亿人感染疟疾，有超过60万人死于这 种蚊媒疾病。坏消息还不止如此，研究显示，蚊子们正在对杀虫剂产生抗药性，且耐药的疟原虫正在出 现。 不过，近日来自加州大学、圣保罗大学和约翰·霍普金斯大学的研究人员发现了一种对抗疟疾的潜在新 工具——通过基因改造，他们将一种在某些蚊子体内自然存在的基因插入蚊子体内，使其能够抵抗疟疾 寄生虫。他们还利用一种名为"基因驱动"的基因技术，在实验室中加速这种基因变体在蚊子群体中的传 播。 上个月，这项研究成果发表在了《自然》杂志上[1]。这种新工具也许有望让人类在战胜疟疾的道路上看 到曙光。 一、传播疟疾的关键基因 "这种特殊变异会产生如此巨大的影响，这似乎很不可思议，"该研究的主要作者伊森·比尔（Ethan Bier）说，"老实说，我仍然无法相信这一点。" 疟疾传播依赖于疟原虫在吸血后成功入侵按蚊中肠，宾夕法尼亚州立大学疟疾研究中 ...

国家卫生健康委今天举行新闻发布会，介绍时令节气与健康有关情况。 江西省寄生虫病防治研究所主任医师丁晟介绍， 2021年我国获世卫组织消除疟疾认证，但每年仍有一些境外输入的疟疾病例，许多人因对疟疾认知不 足，归国后放松警惕，导致病情延误甚至危及生命； 经按蚊叮咬传播是疟疾最主要的传播途径，疟原虫是疟疾的病原体。按蚊吸食感染疟原虫患者的血液 时，疟原虫会进入蚊体内发育繁殖，感染疟原虫的按蚊再次叮咬其他人时，就会将疟原虫注入健康人体 内，从而导致疟疾传播。 境外输入病例如果没有及时发现并治疗，在具备按蚊传播条件的地区可能引起继发传播，恶性疟还容易 发展为重症甚至死亡。因此， 赴非洲、东南亚等疟疾流行区务工、旅行者，出行前应咨询国际旅行卫生保健中心等有关机构，必要时 携带抗疟药作预防或应急治疗。 从疟疾流行区入境后1年内，若出现周期性寒战、高热、大汗或不明原因发热，应立即就医并告知旅行 史。 （总台央视记者 杨阳 史迎春） 同时，传播疟疾的媒介按蚊在我国也广泛存在，疟疾传播的链条可以再现，所以要持续保持防护意识。 ...

Core Insights - The World Health Organization (WHO) reports significant progress in malaria prevention and control, with 46 countries certified as "malaria-free" and 25 countries reporting fewer than 10 cases in 2023 [1][2] - Global malaria cases reached approximately 263 million in 2023, an increase of about 11 million from the previous year, while malaria deaths decreased to around 597,000, a reduction of 11,000 [1][2] - Africa accounted for 94% of global malaria cases and 95% of malaria deaths in 2023, prompting several African nations to implement reforms to reduce incidence [1][2] Funding and Challenges - Despite progress, funding gaps and climate change pose significant challenges to malaria control efforts, with global funding estimated at $4 billion in 2023, a slight decrease from $4.1 billion in 2022 [2][3] - The WHO's 2016-2030 Global Malaria Technical Strategy set a target of $8.3 billion in funding for 2023, indicating only 48% of the required funds were raised [2][3] Climate Change Impact - Climate change is altering the distribution of malaria vectors and increasing transmission risks, with extreme weather events creating more breeding grounds for mosquitoes [3] - Natural disasters have led to increased malaria cases in southeastern Africa, with Malawi and Mozambique reporting increases of 3.1% and 3.9%, respectively, from 2022 to 2023 [3] Global Contributions - China has played a significant role in global malaria control by promoting artemisinin and providing various forms of support, including training for over 2,000 health officials in 85 countries [4] - The malaria death rate in Africa has decreased significantly, with over 100 million patients receiving artemisinin treatment annually, saving millions of lives [4]

Core Viewpoint - Malaria has been a significant global health threat, but China has successfully eliminated it, largely due to the discovery of artemisinin by Tu Youyou, marking a remarkable achievement in public health [1][12]. Group 1: Historical Context of Malaria in China - Malaria, known as "打摆子," is a mosquito-borne infectious disease caused by Plasmodium, characterized by periodic fever and chills, leading to severe health issues and high mortality rates [3]. - Before the establishment of New China, there were approximately 30 million malaria cases annually, with around 300,000 deaths, resulting in a mortality rate of 1% [3]. - The peak of malaria cases in China occurred in 1970, with over 24 million reported cases [3]. Group 2: Development of Artemisinin - Prior to the introduction of artemisinin, the main treatments for malaria were quinine and chloroquine, which became less effective due to drug resistance [5]. - In 1969, Tu Youyou was appointed to lead the "523" project aimed at developing new anti-malarial drugs, marking the beginning of her significant contributions to malaria treatment [5][9]. - Tu Youyou compiled over 640 traditional Chinese medicinal recipes for malaria treatment and conducted hundreds of experiments, ultimately leading to the discovery of artemisinin [9]. Group 3: Clinical Trials and Recognition - To ensure the safety of artemisinin, Tu Youyou volunteered to test the drug herself, stating her responsibility as the team leader [9][10]. - In July 1972, Tu and her team confirmed the safety of artemisinin through clinical trials [10]. - Tu Youyou received the Nobel Prize in Physiology or Medicine in 2015 for her groundbreaking work on artemisinin, marking a significant milestone for Chinese scientific research [12][15]. Group 4: Impact and Ongoing Research - Since the introduction of artemisinin, it has saved millions of lives globally, with the World Health Organization estimating that it treats hundreds of millions of patients each year [16]. - On June 30, 2021, the WHO awarded China with a certification for malaria elimination, recognizing the country's efforts from 30 million cases annually to complete eradication [16]. - Despite the elimination of malaria, research on artemisinin continues in China, highlighting the ongoing commitment to scientific advancement [16].